Società Acasti Pharma Inc Toronto S.E.
Azioni
APO
CA00430K4028
Prodotti farmaceutici
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01/08/21 |
Director of Finance/CFO | 52 | 05/01 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/05/23 |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 62 | 08/05/23 |
Amresh Kumar
PRN | Corporate Officer/Principal | 44 | 15/05/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 10/10/23 |
Director/Board Member | - | 10/10/23 | |
Santosh Kottayil
BRD | Director/Board Member | 60 | 10/10/23 |
Chairman | 55 | 27/08/21 | |
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01/08/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 9 399 404 | 7 893 546 ( 83,98 %) | 0 | 83,98 % |
Coordinate società
![Indirizzo Acasti Pharma Inc(APO)](https://cdn.zonebourse.com/static/address/7711546.png)
Settore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+51,63% | 796 Mrd | |
+41,51% | 628 Mrd | |
-5,10% | 358 Mrd | |
+19,90% | 331 Mrd | |
+9,95% | 301 Mrd | |
+17,66% | 244 Mrd | |
+3,39% | 228 Mrd | |
+10,75% | 214 Mrd | |
+6,99% | 165 Mrd |